Stay updated with breaking news from Daniel Longley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Queen’s University Belfast has announced its 100th spin-out company - AilseVax - with seed funding of £1.5M from a group of investors.
Ipsen and Domainex collaboration will provide an exclusive licence to develop innovative inhibitors and pioneering cancer treatments - News - PharmaTimes
Saffron Walden, 26th January 2022 / Sciad Newswire / Domainex Ltd., a leading provider of integrated drug discovery services to life science organisations globally, is delighted that Professors Daniel Longley, Tim Harrison and colleagues at Queen’s University Belfast have entered into a collaboration and licensing a...